Insurer To Encourage Prescription Drugs To Help With Opioid Addiction
A multi-pronged initiative that Neighborhood Health Plan is announcing Friday aims to reduce the number of opioid overdose deaths by increasing access to treatment.
View ArticleFlouting Guidelines, Most Colorado Dispensaries Recommend Cannabis For...
They recommended cannabis even though Colorado requires warnings on the packaging of cannabis products about risks to pregnant and breastfeeding women.
View ArticleWhy The Abortion Fight Is Becoming A Battle Over Health Information
The latest White House move focuses on clinics, but online sales of of abortion drugs mean women don't necessarily need access to a clinic to end an early pregnancy.
View ArticleOpioid Death Rate Declined In Mass. In 2017 — Except For Blacks
Fentanyl is still the main suspected cause of death. It was present in 85 percent of all opioid-related deaths in 2017.
View ArticleDo High-Deductible Plans Make Even Cancer Care A Luxury Item?
Rosemarie Day, one of the founding leaders of the Health Connector, worries that increasingly popular high-deductible plans can lead to poor medical decisions -- and worse outcomes for patients.
View ArticleBrigham And Women's Nurse Who Sued For Retaliation Awarded $28 Million
A jury has ruled that a Boston hospital retaliated against a Haitian-American nurse who stood up for a black colleague and has awarded her $28 million.
View ArticleBlack Drug Users Grapple With Surging Opioid Overdose Death Rates
Opioid overdose death rates are steady or dropping for most drug users in Massachusetts, but rising among blacks.
View ArticleA Harvard Psychiatrist's Plea To CVS: Please, Please Change Your Hold Music
Dr. Steve Schlozman calculates that he's spent almost 25 days of his life listening to the same CVS "hold" piano music on the phone. He can't take much more.
View Article'Morbid Acceptance': Visualizing My Death As I Face The Next Cancer Scan
"Imaginings of my own death began to swirl in my mind. I wondered if it would still be summer at my funeral, or maybe fall. I thought about the specific photos and videos I wanted my little son to...
View ArticleNorth Shore Medical Partnership Seeks Earlier End-Of-Life Conversations
The earlier conversations are seen as a way to avoid hospital visits and lower stress and health costs.
View ArticleBig Mass. Employers Aim To Cut Health Costs, Starting With $100M In Unneeded...
But there's a dispute about just how many emergency department visits are avoidable.
View ArticleNext Week: WBUR's 'BioBoom' Series, On Greater Boston's Burgeoning Biotech
Join WBUR the week of June 4 for the "BioBoom" series exploring the what, who and why of what many consider the world's leading biotech cluster, centered in Kendall Square, Cambridge.
View ArticlePrimer: How To Speak Basic Biotech, From 'Transformative' To 'Valley Of Death'
The Boston area's booming biotech cluster is a little like a country with its own culture. And cultures tend to have languages.
View ArticleBoston's Vertex Has Taken A Roller Coaster Ride To Profitability
Along the way Vertex got a boost from a unique funding source and, as a result, developed an unusual business model.
View ArticleBiotech Startups: Dreams, Risk, Failure And — Sometimes — Success
Hundreds of startups help power the Boston area's biotech boom, but it's widely accepted that failures vastly exceed successes.
View ArticleTribes Of Kendall Square: How To Parse Who's Who In Hotbed Of Biotech
The dense Boston-area cluster of biotech has a culture and cast of characters all its own -- academics, entrepreneurs, venture capitalists -- much as Silicon Valley does.
View ArticleFrom Tough Love To Empathy: Coaching For Parents With Opioid-Addicted Children
Parents caught up in the opioid epidemic with their adult children are often advised to show "tough love." But a gentler, more collaborative method is helping some parents to help their children get...
View ArticleThis Biotech Unicorn Hopes To Revolutionize Drug Making, But It Has Its Skeptics
Investors think Moderna Therapeutics holds a lot of promise -- a new technology that could revolutionize thousands of medicines.
View ArticleOne Of Biotech's Biggest Investors Says The Industry Must Be 'Unreasonable'
Noubar Afeyan is one of biotech's most prolific investors.
View ArticleAffording Miracles: As Biotech Victories In Gene Therapy Excite, Costs Spur...
The first-approved gene therapy costs an eye-popping $142,000 per drop, helping to spur the quest to find better ways of pricing and paying for these miraculous new treatments.
View Article